When to Use Hormone Therapy with Radiation Therapy
Nutrition and Prostate Cancer What We Think We Know and What We Actually Know
Testosterone and Prostate Cancer: Is There a Link?
Active Surveillance Results and Implications of Prospective Studies
Intermittent HT, Quality of Life, and Testosterone Recovery
Radium-223 in Advanced Disease
2021 Prostate Cancer Patient Conference | Day 1
Personalized Therapy for Prostate Cancer due to Genetic Testings
Urinary Morbidity Prevention and Management
Patterns of Failure Following the Brachytherapy Management of Prostate Cancer
Targeted Focal Therapy for Localized Prostate Cancer
Day 2 #ProstateCancer Active Surveillance, Advanced Treatments, Q&A | PCRI 2023 Conference
PROVEN: In 26,000 Men - True Gleason 6 Prostate Cancer Does Not Metastasize | 2019 PCRI Conference
Metabolic Side Effects of ADT
New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRI
PSA Recurrence, Risk Assessment - 2021 Prostate Cancer Patient Conference
Diet and Exercise as Part of Your Prostate Cancer Treatment Plan - 2021 Prostate Cancer Conference
2023 Mid-Year #ProstateCancer Patient Conference | #MarkMoyadMD #MarkScholzMD #PCRI
PSMA PET and Functional Imaging - 2021 Prostate Cancer Patient Conference
Androgen Deprivation Therapy and Prostate Cancer
Day 2 | Advanced Treatments, LU-177, Extended Q+A | 2022 Prostate Cancer Patient Conference
Localized Prostate Cancer: Radiation - 2021 Prostate Cancer Patient Conference
The Impact of BPH and Management of Prostate Cancer Obesity in Urology
2020 Prostate Cancer Patient Conference: DAY 1 | 9:30AM PDT
Recurrent Prostate Cancer Cases - 2021 Prostate Cancer Patient Conference
Localized Prostate Cancer Cases - 2021 Prostate Cancer Patient Conference
ADT Resistant Metastatic Prostate Cancer (mCRPC) - 2021 Prostate Cancer Patient Conference
Localized Prostate Cancer: Active Surveillance - 2021 Prostate Cancer Patient Conference
PSMA Targeting for Treatment of Advanced Prostate Cancer - 2021 Prostate Cancer Patient Conference
Overview: Advanced Prostate Cancer Treatments | Tanya Dorff, MD | 2021 PCRI Conference
Localized Prostate Cancer: Risk Stratification - 2021 Prostate Cancer Patient Conference
How Should We Monitor Patients During Surveillance?
Systemic Therapy Options for "PSA Only" Disease - 2021 Prostate Cancer Patient Conference
Oligometastatic Disease - 2021 Prostate Cancer Patient Conference
Localized Prostate Cancer: Surgery - 2021 Prostate Cancer Patient Conference
Untreated Metastatic Prostate Cancer - 2021 Prostate Cancer Patient Conference
Impact of Lifestyle and Exercise on Prostate Cancer, Mark Moyad, MD, MPH | 2018 PCRI Conference
ADT Resistant Non-Metastatic Prostate Cancer (nmCRPC) - 2021 Prostate Cancer Patient Conference
Prostate cancer symposium
Radiotherapy for Localized Prostate Cancer
Recurrent Prostate Cancer Cases Panel
Prostate Cancer Epidemiology, Screening and Diagnosis - 2021 Prostate Cancer Patient Conference
Jolt PEMF Lab | Effective Prostate Cancer Treatment in Scottsdale, Arizona
2019-Avril "Cancer de la prostate: Surveillance active, chirurgie ou radiothérapie?"
Prostate Cancer Conference Highlights from ASCO 2023
Advanced Prostate Cancer Cases
Prostate Cancer Conference Highlights from ASCO GU 2023
Holistic Treatment For Prostate Cancer in Scottsdale, AZ | Brio Medical Alternative Cancer Clinic
Prostate Cancer Conference Highlights from ASCO 2022
Managing Prostate Cancer Treatment Side Effects
Race, Racism and Prostate Cancer Disparities - 2021 Prostate Cancer Patient Conference
Radiation, PSMA, Immune Therapy | Questions From The PCRI Mid-Year Update | Mark Scholz, MD
Prostate Cancer Treatment Overview: What's Changing - Summit 2021
Introduction - 2021 Prostate Cancer Patient Conference
Q&A: Prostate Cancer Symposium
Prostate Cancer Active Surveillance
Staging Prostate Cancer, PSA Screening, and What If You Have a High PSA? | Mark Scholz, MD | PCRI
Advanced Prostate Cancer Story: Jan Manarite Advocated For Her Husband For 13 Years
Prostate Cancer Oligometastases | Dr. Kwon | 2014 Prostate Cancer Patient Conference
